Skip to main content
. 2021 Jun 15;11(6):2537–2567.

Figure 6.

Figure 6

SMI mitigates ASPH induced EMT, stemness and in vitro metastasis. A. Expression of epithelial marker E-cadherin in response to SMI. B. Expression of mesenchymal marker Vimentin in response to SMI. C, D. Expression of cancer stem cell marker EpCAM in response to SMI. E, F. Expression of cancer stem cell marker CD44 in response to SMI. G, H. In vitro metastasis in response to SMI. *P < 0.05; **P < 0.01; ***P < 0.001.